SE446189B - Forfarande for framstellning av optiskt aktiva oxazafosforinderivat - Google Patents

Forfarande for framstellning av optiskt aktiva oxazafosforinderivat

Info

Publication number: SE446189B
Authority: SE; Sweden
Prior art keywords: process according; compound; reaction; general formula; cyclophosphamide
Prior art date: 1978-05-29

Application number

SE7904595A

Other languages

English (en)

Swedish (sv)

Other versions

SE7904595L (sv

Inventor

T Sato

Original Assignee

Otsuka Pharma Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1978-05-29

Filing date

1979-05-28

Publication date

1986-08-18

1979-05-28 Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd

1979-11-30 Publication of SE7904595L publication Critical patent/SE7904595L/

1986-08-18 Publication of SE446189B publication Critical patent/SE446189B/sv

Links

238000000034 method Methods 0.000 title claims description 29
ZZVDXRCAGGQFAK-UHFFFAOYSA-N 2h-oxazaphosphinine Chemical class N1OC=CC=P1 ZZVDXRCAGGQFAK-UHFFFAOYSA-N 0.000 title claims description 6
238000002360 preparation method Methods 0.000 title claims description 5
238000006243 chemical reaction Methods 0.000 claims description 44
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 28
UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 18
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical group CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 18
239000002904 solvent Substances 0.000 claims description 18
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 16
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 15
150000007514 bases Chemical class 0.000 claims description 13
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 12
XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 claims description 11
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 10
RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 7
LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 claims description 6
IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims description 6
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 5
YFNKIDBQEZZDLK-UHFFFAOYSA-N triglyme Chemical compound COCCOCCOCCOC YFNKIDBQEZZDLK-UHFFFAOYSA-N 0.000 claims description 5
ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 claims description 4
JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 claims description 4
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 4
SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 claims description 4
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 4
150000003512 tertiary amines Chemical class 0.000 claims description 4
WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 claims description 3
NHTMVDHEPJAVLT-UHFFFAOYSA-N Isooctane Chemical compound CC(C)CC(C)(C)C NHTMVDHEPJAVLT-UHFFFAOYSA-N 0.000 claims description 3
150000001414 amino alcohols Chemical class 0.000 claims description 3
150000004945 aromatic hydrocarbons Chemical class 0.000 claims description 3
JVSWJIKNEAIKJW-UHFFFAOYSA-N dimethyl-hexane Natural products CCCCCC(C)C JVSWJIKNEAIKJW-UHFFFAOYSA-N 0.000 claims description 3
229910052739 hydrogen Inorganic materials 0.000 claims description 3
239000001257 hydrogen Substances 0.000 claims description 3
BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 3
229930195734 saturated hydrocarbon Natural products 0.000 claims description 3
XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims description 2
CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 2
CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 2
229910052801 chlorine Inorganic materials 0.000 claims description 2
125000001309 chloro group Chemical group Cl* 0.000 claims description 2
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 2
RKBCYCFRFCNLTO-UHFFFAOYSA-N triisopropylamine Chemical compound CC(C)N(C(C)C)C(C)C RKBCYCFRFCNLTO-UHFFFAOYSA-N 0.000 claims description 2
239000008096 xylene Substances 0.000 claims description 2
150000001338 aliphatic hydrocarbons Chemical class 0.000 claims 2
125000000217 alkyl group Chemical group 0.000 claims 2
125000004435 hydrogen atom Chemical class [H]* 0.000 claims 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
229910000027 potassium carbonate Inorganic materials 0.000 claims 1
150000001875 compounds Chemical class 0.000 description 78
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 20
HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 16
206010028980 Neoplasm Diseases 0.000 description 16
229960004397 cyclophosphamide Drugs 0.000 description 16
CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 15
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
239000013078 crystal Substances 0.000 description 11
239000000243 solution Substances 0.000 description 10
241000699670 Mus sp. Species 0.000 description 9
238000002844 melting Methods 0.000 description 9
230000008018 melting Effects 0.000 description 9
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 8
230000000694 effects Effects 0.000 description 7
239000000203 mixture Substances 0.000 description 7
229910052698 phosphorus Inorganic materials 0.000 description 7
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
230000000259 anti-tumor effect Effects 0.000 description 6
238000000921 elemental analysis Methods 0.000 description 6
XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 6
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 6
FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 6
238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 5
-1 phosphorus compound Chemical class 0.000 description 5
239000000126 substance Substances 0.000 description 5
238000012360 testing method Methods 0.000 description 5
229940086542 triethylamine Drugs 0.000 description 5
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
125000001340 2-chloroethyl group Chemical group [H]C([H])(Cl)C([H])([H])* 0.000 description 4
CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
238000012658 bimolecular nucleophilic substitution Methods 0.000 description 4
229910052799 carbon Inorganic materials 0.000 description 4
210000004027 cell Anatomy 0.000 description 4
SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 4
239000000706 filtrate Substances 0.000 description 4
238000002329 infrared spectrum Methods 0.000 description 4
239000010410 layer Substances 0.000 description 4
239000011574 phosphorus Substances 0.000 description 4
239000007787 solid Substances 0.000 description 4
238000001228 spectrum Methods 0.000 description 4
239000007858 starting material Substances 0.000 description 4
125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 3
QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical group [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 description 3
239000007864 aqueous solution Substances 0.000 description 3
230000037396 body weight Effects 0.000 description 3
150000001721 carbon Chemical group 0.000 description 3
238000005660 chlorination reaction Methods 0.000 description 3
ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 3
MCWXGJITAZMZEV-UHFFFAOYSA-N dimethoate Chemical compound CNC(=O)CSP(=S)(OC)OC MCWXGJITAZMZEV-UHFFFAOYSA-N 0.000 description 3
238000001914 filtration Methods 0.000 description 3
150000008282 halocarbons Chemical class 0.000 description 3
239000012044 organic layer Substances 0.000 description 3
125000004437 phosphorous atom Chemical group 0.000 description 3
239000011541 reaction mixture Substances 0.000 description 3
239000011780 sodium chloride Substances 0.000 description 3
BNNZCELZKQKDQY-UHFFFAOYSA-N 1,3,2-oxazaphosphinan-2-ium 2-oxide Chemical compound O=[P+]1NCCCO1 BNNZCELZKQKDQY-UHFFFAOYSA-N 0.000 description 2
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
IVRMZWNICZWHMI-UHFFFAOYSA-N Azide Chemical compound [N-]=[N+]=[N-] IVRMZWNICZWHMI-UHFFFAOYSA-N 0.000 description 2
XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 2
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
208000028018 Lymphocytic leukaemia Diseases 0.000 description 2
FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 2
SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 2
208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 2
OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
231100000403 acute toxicity Toxicity 0.000 description 2
230000007059 acute toxicity Effects 0.000 description 2
230000002411 adverse Effects 0.000 description 2
150000001408 amides Chemical class 0.000 description 2
SLUNEGLMXGHOLY-UHFFFAOYSA-N benzene;hexane Chemical compound CCCCCC.C1=CC=CC=C1 SLUNEGLMXGHOLY-UHFFFAOYSA-N 0.000 description 2
238000009903 catalytic hydrogenation reaction Methods 0.000 description 2
239000012320 chlorinating reagent Substances 0.000 description 2
239000000460 chlorine Substances 0.000 description 2
238000001816 cooling Methods 0.000 description 2
238000002425 crystallisation Methods 0.000 description 2
230000008025 crystallization Effects 0.000 description 2
239000000975 dye Substances 0.000 description 2
ZKQFHRVKCYFVCN-UHFFFAOYSA-N ethoxyethane;hexane Chemical compound CCOCC.CCCCCC ZKQFHRVKCYFVCN-UHFFFAOYSA-N 0.000 description 2
238000007327 hydrogenolysis reaction Methods 0.000 description 2
230000002401 inhibitory effect Effects 0.000 description 2
239000002198 insoluble material Substances 0.000 description 2
208000032839 leukemia Diseases 0.000 description 2
208000003747 lymphoid leukemia Diseases 0.000 description 2
239000000463 material Substances 0.000 description 2
UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 2
239000012434 nucleophilic reagent Substances 0.000 description 2
206010033675 panniculitis Diseases 0.000 description 2
230000000144 pharmacologic effect Effects 0.000 description 2
230000035755 proliferation Effects 0.000 description 2
BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
238000001953 recrystallisation Methods 0.000 description 2
229920006395 saturated elastomer Polymers 0.000 description 2
238000003756 stirring Methods 0.000 description 2
238000006467 substitution reaction Methods 0.000 description 2
238000002054 transplantation Methods 0.000 description 2
RTAHEODDAQYTQU-HWPZZCPQSA-N (2R)-2-chloro-3-[(1R)-1-phenylethyl]-1,3,2lambda5-oxazaphosphinane 2-oxide Chemical compound Cl[P@@]1(OCCCN1[C@@H](C1=CC=CC=C1)C)=O RTAHEODDAQYTQU-HWPZZCPQSA-N 0.000 description 1
CMSMOCZEIVJLDB-AWEZNQCLSA-N (2s)-n,n-bis(2-chloroethyl)-2-oxo-1,3,2$l^{5}-oxazaphosphinan-2-amine Chemical compound ClCCN(CCCl)[P@]1(=O)NCCCO1 CMSMOCZEIVJLDB-AWEZNQCLSA-N 0.000 description 1
AXBVSRMHOPMXBA-UHFFFAOYSA-N 4-nitrothiophenol Chemical group [O-][N+](=O)C1=CC=C(S)C=C1 AXBVSRMHOPMXBA-UHFFFAOYSA-N 0.000 description 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
208000017604 Hodgkin disease Diseases 0.000 description 1
208000010747 Hodgkins lymphoma Diseases 0.000 description 1
208000005045 Interdigitating dendritic cell sarcoma Diseases 0.000 description 1
KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 1
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical group OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
239000007868 Raney catalyst Substances 0.000 description 1
NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
229910000564 Raney nickel Inorganic materials 0.000 description 1
210000000683 abdominal cavity Anatomy 0.000 description 1
239000002253 acid Substances 0.000 description 1
231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
238000011047 acute toxicity test Methods 0.000 description 1
239000002246 antineoplastic agent Substances 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
239000012267 brine Substances 0.000 description 1
244000309464 bull Species 0.000 description 1
235000011089 carbon dioxide Nutrition 0.000 description 1
239000003054 catalyst Substances 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
229940125773 compound 10 Drugs 0.000 description 1
DMSZORWOGDLWGN-UHFFFAOYSA-N ctk1a3526 Chemical compound NP(N)(N)=O DMSZORWOGDLWGN-UHFFFAOYSA-N 0.000 description 1
239000000539 dimer Substances 0.000 description 1
YWEUIGNSBFLMFL-UHFFFAOYSA-N diphosphonate Chemical compound O=P(=O)OP(=O)=O YWEUIGNSBFLMFL-UHFFFAOYSA-N 0.000 description 1
238000004821 distillation Methods 0.000 description 1
239000003814 drug Substances 0.000 description 1
239000004210 ether based solvent Substances 0.000 description 1
HBFXVTVOSLPOEY-UHFFFAOYSA-N ethoxyethane;2-propan-2-yloxypropane Chemical compound CCOCC.CC(C)OC(C)C HBFXVTVOSLPOEY-UHFFFAOYSA-N 0.000 description 1
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
239000012530 fluid Substances 0.000 description 1
239000011888 foil Substances 0.000 description 1
230000003325 follicular Effects 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
GTVRLHPVICIJFQ-UHFFFAOYSA-N hexane;tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl.CCCCCC GTVRLHPVICIJFQ-UHFFFAOYSA-N 0.000 description 1
150000007529 inorganic bases Chemical class 0.000 description 1
239000000543 intermediate Substances 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 1
239000007788 liquid Substances 0.000 description 1
230000000527 lymphocytic effect Effects 0.000 description 1
208000025036 lymphosarcoma Diseases 0.000 description 1
229910052943 magnesium sulfate Inorganic materials 0.000 description 1
235000019341 magnesium sulphate Nutrition 0.000 description 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
239000012452 mother liquor Substances 0.000 description 1
125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
239000012038 nucleophile Substances 0.000 description 1
238000010534 nucleophilic substitution reaction Methods 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 1
DLYUQMMRRRQYAE-UHFFFAOYSA-N phosphorus pentoxide Inorganic materials O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 1
229910003446 platinum oxide Inorganic materials 0.000 description 1
239000002798 polar solvent Substances 0.000 description 1
239000000047 product Substances 0.000 description 1
239000012429 reaction media Substances 0.000 description 1
208000029922 reticulum cell sarcoma Diseases 0.000 description 1
229910052703 rhodium Inorganic materials 0.000 description 1
239000010948 rhodium Substances 0.000 description 1
MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 1
229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
235000017557 sodium bicarbonate Nutrition 0.000 description 1
229910000029 sodium carbonate Inorganic materials 0.000 description 1
HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
238000010998 test method Methods 0.000 description 1
VSWLXYAZJZQIKA-UHFFFAOYSA-N tetrachloromethane;triphenylphosphane Chemical compound ClC(Cl)(Cl)Cl.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 VSWLXYAZJZQIKA-UHFFFAOYSA-N 0.000 description 1
229940124597 therapeutic agent Drugs 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
ILWRPSCZWQJDMK-UHFFFAOYSA-N triethylazanium;chloride Chemical compound Cl.CCN(CC)CC ILWRPSCZWQJDMK-UHFFFAOYSA-N 0.000 description 1
ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6581—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
- C07F9/6584—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having one phosphorus atom as ring hetero atom
- C07F9/65842—Cyclic amide derivatives of acids of phosphorus, in which one nitrogen atom belongs to the ring
- C07F9/65846—Cyclic amide derivatives of acids of phosphorus, in which one nitrogen atom belongs to the ring the phosphorus atom being part of a six-membered ring which may be condensed with another ring system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/22—Amides of acids of phosphorus
- C07F9/26—Amides of acids of phosphorus containing P-halide groups

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

SE7904595A 1978-05-29 1979-05-28 Forfarande for framstellning av optiskt aktiva oxazafosforinderivat SE446189B (sv)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP6468178A JPS54157580A (en)	1978-05-29	1978-05-29	Optically active oxazaphosphorine derivative

Publications (2)

Publication Number	Publication Date
SE7904595L SE7904595L (sv)	1979-11-30
SE446189B true SE446189B (sv)	1986-08-18

Family

ID=13265139

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE7904595A SE446189B (sv)	1978-05-29	1979-05-28	Forfarande for framstellning av optiskt aktiva oxazafosforinderivat

Country Status (14)

Country	Link
US (1)	US4239709A (fr)
JP (1)	JPS54157580A (fr)
AU (1)	AU516429B2 (fr)
BE (1)	BE876578A (fr)
CA (1)	CA1108175A (fr)
CH (1)	CH646710A5 (fr)
DE (1)	DE2921057C3 (fr)
ES (1)	ES481026A1 (fr)
FR (1)	FR2427339A1 (fr)
GB (1)	GB2021591B (fr)
IT (1)	IT1120976B (fr)
NL (1)	NL183141C (fr)
SE (1)	SE446189B (fr)
SU (1)	SU867314A3 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3111428A1 (de)	1981-03-24	1982-10-07	Asta-Werke Ag, Chemische Fabrik, 4800 Bielefeld	Oxazaphosphorin-4-thio-alkansulfonsaeuren und deren neutrale salze, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
US5229162A (en) *	1984-01-20	1993-07-20	Biocompatibles Ltd.	Article having biocompatible surface
US5380904A (en) *	1984-01-20	1995-01-10	Biocompatibles Ltd.	Process for rendering a surface biocompatible, and articles containing the same
GB8401534D0 (en) *	1984-01-20	1984-02-22	Royal Free Hosp School Med	Biocompatible surfaces
ZA851062B (en) *	1984-03-01	1985-11-27	Asta Werke Ag Chem Fab	Salts of oxazaphosphorine derivatives and process for their production
FR2567129B1 (fr) *	1984-07-06	1986-12-05	Adir	Nouveaux derives de l'oxaazaphosphorine, leur procede de preparation et les compositions pharmaceutiques les renfermant
US5258538A (en) *	1985-08-26	1993-11-02	Applied Biosystems, Inc.	2,3-disubstituted-1,3,2-oxazaphosphacycloalkanes as nucleic acid linking agents
KR900013763A (ko) *	1989-02-28	1990-09-05	안시환	모사전송기의 원고 급지장치
DE19739159C1 (de) *	1997-09-06	1999-01-28	Asta Medica Ag	Verfahren zur Herstellung von Oxazaphosphorin-2-aminen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1203268B (de) *	1961-10-26	1965-10-21	Farmochimica Cutolo Calosi S P	Verfahren zur Herstellung von 2-Chlor-3, 4-dimethyl-5-phenyl-1, 3, 2-oxazophospholidin-2-on
US3732340A (en) *	1966-07-11	1973-05-08	Asta Werke Ag Chem Fab	N',o-propylene phosphoric acid ester diamides
GB1235022A (en) *	1969-06-04	1971-06-09	Laeaeke Ag	A new method for the production of cyclophosphamide
DE2201675A1 (de) *	1972-01-14	1973-07-19	Asta Werke Ag Chem Fab	Alkylsulfonsaeureester 1,3,2-oxazaphospha-cyclischer verbindungen, verfahren zu ihrer herstellung und pharmazeutische praeparate
PL100390B1 (pl) *	1975-10-06	1978-09-30		Sposob wytwarzania 2-tlenku-2-/bis/2-chloroetylo/-amino/-1-/okso-3-aza-2-fosfacykloheksanu/cyklofosfamidu/o czynnosci optycznej

1978
- 1978-05-29 JP JP6468178A patent/JPS54157580A/ja active Granted
1979
- 1979-05-23 DE DE2921057A patent/DE2921057C3/de not_active Expired
- 1979-05-23 CA CA328,094A patent/CA1108175A/fr not_active Expired
- 1979-05-25 SU SU792769753A patent/SU867314A3/ru active
- 1979-05-28 SE SE7904595A patent/SE446189B/sv not_active IP Right Cessation
- 1979-05-28 IT IT68144/79A patent/IT1120976B/it active
- 1979-05-28 CH CH494979A patent/CH646710A5/de not_active IP Right Cessation
- 1979-05-28 AU AU47477/79A patent/AU516429B2/en not_active Ceased
- 1979-05-28 BE BE0/195419A patent/BE876578A/fr not_active IP Right Cessation
- 1979-05-29 NL NLAANVRAGE7904215,A patent/NL183141C/xx not_active IP Right Cessation
- 1979-05-29 ES ES481026A patent/ES481026A1/es not_active Expired
- 1979-05-29 GB GB7918581A patent/GB2021591B/en not_active Expired
- 1979-05-29 FR FR7913639A patent/FR2427339A1/fr active Granted
- 1979-05-29 US US06/043,462 patent/US4239709A/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
CA1108175A (fr)	1981-09-01
NL183141B (nl)	1988-03-01
NL183141C (nl)	1988-08-01
AU516429B2 (en)	1981-06-04
DE2921057B2 (de)	1981-01-15
US4239709A (en)	1980-12-16
DE2921057A1 (de)	1979-12-06
SU867314A3 (ru)	1981-09-23
NL7904215A (nl)	1979-12-03
FR2427339A1 (fr)	1979-12-28
DE2921057C3 (de)	1981-11-26
SE7904595L (sv)	1979-11-30
CH646710A5 (de)	1984-12-14
BE876578A (fr)	1979-11-28
AU4747779A (en)	1979-12-06
FR2427339B1 (fr)	1984-09-14
IT1120976B (it)	1986-03-26
IT7968144A0 (it)	1979-05-28
JPS5761360B2 (fr)	1982-12-23
GB2021591B (en)	1982-09-08
JPS54157580A (en)	1979-12-12
GB2021591A (en)	1979-12-05
ES481026A1 (es)	1980-02-01

Legal Events

Date

Code

Title

Description

1995-01-31

NUG

Patent has lapsed

Ref document number: 7904595-1

Effective date: 19911209

Format of ref document f/p: F

Publication	Publication Date	Title
SE446189B (sv)	1986-08-18	Forfarande for framstellning av optiskt aktiva oxazafosforinderivat
DE1445743A1 (de)	1968-12-19	Verfahren zur Herstellung von in 2-Stellung substituierten Benzoxazinonen
DE69128477T2 (de)	1998-07-16	Benzopyranderivat
CN113372276B (zh)	2022-04-22	吲唑类衍生物及其应用
US20040073054A1 (en)	2004-04-15	New fluorous tagging and scavenging reactants and methods of synthesis and use thereof
US4075409A (en)	1978-02-21	Benzophenone derivatives
Friedman et al.	1954	Preparation of Secondary Amine Mustards with High Toxicity1a
Katritzky et al.	1995	Synthesis and reactivity of 2, 6‐diamino‐4‐methyl‐3‐pyridinecarbonitrile
KR102451135B1 (ko)	2022-10-06	오르쏘-카보레인-융합 피라졸 화합물 및 이의 제조방법
EP3016962B1 (fr)	2018-02-28	Dérivés de 2-cyano-2-aminobenzoate-propyl organométalliques et leur utilisation comme anthelminthiques
RU2785197C1 (ru)	2022-12-05	3-Метил-8-(4-метоксифенил)-2-тиоксо-3a,5-ди(4-толил)-1,2,3,3a-тетрагидро-6H-пирроло[2',3':3,4]фуро[2,3-d]имидазол-6,7(8H)-дион, обладающий противомикробной активностью, и способ его получения
RU2831251C1 (ru)	2024-12-03	Способ получения 3-гидрокси-1-(2-гидроксифенил)-7a-(1H-индол-3-ил)-4-фенил-1,7a-дигидро-2H-пирроло[2,3-d]пиридазин-2,7(6H)-диона в качестве средства, обладающего противотуберкулезной активностью
RU2798423C1 (ru)	2023-06-22	Применение 9-ароил-8-гидрокси-6-(2-гидроксиэтил)-1,3,6-триазаспиро[4,4]нон-8-ен-2,4,7-трионов в качестве средств, обладающих противотуберкулезной активностью
RU2767555C1 (ru)	2022-03-17	Способ получения 9-ароил-8-гидрокси-6-(2-гидроксиарил)-1,3-дифенил-1,3,6-триазаспиро[4.4]нон-8-ен-2,4,7-трионов, обладающих противомикробной активностью
RU2767558C1 (ru)	2022-03-17	Способ получения 9-ароил-8-гидрокси-6-(2-гидроксиарил)-3-фенил-1,3,6-триазаспиро[4.4]нон-8-ен-2,4,7-трионов, обладающих противомикробной активностью
Kakanejadifard et al.	2022	Synthesis, Characterization, Crystal Structure and Density Functional Investigation of dialkyl (phenyl ((4-(phenyl diazenyl) phenyl) amino) methyl) Phosphonate
SU245769A1 (ru)		Способ получения 1,4-бис-[диамидо(гидразидо) тиофосфорил]-бензолов
US3979411A (en)	1976-09-07	2-Trifluoromethylimino-benzo-heterocyclic compounds
PL142219B1 (en)	1987-10-31	Method of obtaining novel aziridinylcyclotriphosphazenes
US9598451B2 (en)	2017-03-21	Bis-organometallic 2-amino-3-hydroxy-2-methylpropanenitrile derivatives for use as anthelmintics
CA2923346A1 (fr)	2015-04-02	N-2-cyano-1-hydroxypropan-2-yle organometallique a utiliser comme anthelminthique
JPS63439B2 (fr)	1988-01-07
Brown et al.	0	Full Text HTML
JPS5913515B2 (ja)	1984-03-30	ビスオキサゾリルエチレンカゴウブツノセイゾウホウ
CA2923370A1 (fr)	2015-04-02	Composes organometalliques a utiliser comme anthelmintiques